News

BUHLMANN fCAL® turbo Highlights

  BÜHLMANN fCAL® turbo Stool extracts used in the BÜHLMANN fCAL® turbo on clinical chemistry analysers can be applied without any concern of system contamination. BÜHLMANN investigated this new sample matrix with the goal to exclude potential risks. Extensive data has been generated to demonstrate that our assay excludes neglectable microbial contamination, bacterial sample carry over and

Read more

New application note for Abbott Architect improves number of tests per kit

BÜHLMANN improved the efficiency of the application by reducing the pipetting volumes to a minimum and applying a different dispense mode within the application. The performance of the assay has been confirmed and no changes in the specifications were found. Today, BÜHLMANN offers this new application with an improved cost/performance ratio. The new application note

Read more

Connect with BUHLMANN at ECCO 2017

BÜHLMANN will be present with a Booth at ECCO. Don’t miss the chance to get an update on our divers calprotectin product portfolio

Read more

Basophil Activation Testing

In a new in-depth article Michele Romano, PhD, responsible at BÜHLMANN for the Product Management of the CAST® Assays for Basophil Activation Tests (BAT), writes about the benefits of using BAT assays in drug discovery and preclinical evaluation of kinase inhibitors.

Read more